OCTOBER 25, 2016

Irritable Bowel Syndrome: Diagnosis and Treatment

Brooks D. Cash, MD, AGAF, FACP, FACG, FASGE
Professor of Medicine
Division of Gastroenterology
University of South Alabama
Mobile, Alabama
Dr. Cash has served as a consultant and/or on the speaker bureau for the following companies: Allergan, AstraZeneca, IM HealthScience, Ironwood, Takeda, and Valeant.

Irritable bowel syndrome (IBS) is a common and important gastrointestinal (GI) condition with a prevalence in North America of between 10% and 15%.1 The syndrome is characterized by abdominal pain